FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2087663721> ?p ?o ?g. }

• W2087663721 endingPage "442" @default.
• W2087663721 startingPage "437" @default.
• W2087663721 abstract "The Assessing Worldwide Antimicrobial Resistance Evaluation Program monitors the activity of ceftaroline and comparator agents tested against pathogens causing either respiratory or skin and soft tissue infections. A total of 7733 isolates from patients in 80 medical centers across the United States (USA) identified as respiratory tract pathogens by the infection type and/or specimen site recorded by the submitting laboratory during 2009-2011 were evaluated. There were 3360 isolates of Streptococcus pneumoniae, 1799 Haemophilus influenzae, 1087 Staphylococcus aureus, 678 Moraxella catarrhalis, 459 Klebsiella pneumoniae, 223 Escherichia coli, and 127 Klebsiella oxytoca. Annual penicillin resistance among S. pneumoniae ranged from 21.9 to 24.3%. All S. pneumoniae strains were inhibited at a ceftaroline MIC of ≤0.5 μg/mL with 100.0% of isolates categorized as susceptible. Ceftaroline was 16-fold more active than ceftriaxone and 32-fold more active than amoxicillin-clavulanate against penicillin-resistant pneumococci. Only 49.8% of the penicillin-resistant isolates were susceptible to ceftriaxone. There were a total of 1087 S. aureus (48.9% methicillin-resistant S. aureus [MRSA]) isolates, and the yearly MRSA rate ranged from 47.9 to 49.7%. The ceftaroline MIC50/90 for S. aureus was at 0.25/1 μg/mL; 98.2% susceptible and no resistant strains (≥4 μg/mL). Ceftaroline activity against methicillin-susceptible S. aureus (MSSA) isolates (MIC50 and MIC90, 0.25 and 0.25 μg/mL, respectively; 100% susceptible) was 2- to 4-fold greater than for MRSA (MIC50/90, 0.5/1 μg/mL; 96.2% susceptible). The ceftriaxone MIC90 for MSSA was 4 μg/mL. Ceftaroline was active against H. influenzae (MIC50/90 ≤0.015/0.03 μg/mL; 100.0% susceptible) and against M. catarrhalis (MIC50/90, 0.06/0.12 μg/mL). Ceftaroline was active against non-extended spectrum β-lactamase (ESBL) phenotype strains of Enterobacteriaceae but not against ESBL-positive phenotype strains. In summary, ceftaroline was highly active against a large collection of bacterial pathogens isolated from patients with respiratory tract infections in the USA during 2009 through 2011." @default.
• W2087663721 created "2016-06-24" @default.
• W2087663721 creator A5006715126 @default.
• W2087663721 creator A5008542312 @default.
• W2087663721 creator A5026620873 @default.
• W2087663721 date "2014-04-01" @default.
• W2087663721 modified "2023-09-23" @default.
• W2087663721 title "Ceftaroline activity against organisms isolated from respiratory tract infections in USA hospitals: results from the AWARE program, 2009–2011" @default.
• W2087663721 cites W1505626160 @default.
• W2087663721 cites W1595237807 @default.
• W2087663721 cites W1981158065 @default.
• W2087663721 cites W1995978627 @default.
• W2087663721 cites W2012617927 @default.
• W2087663721 cites W2034794380 @default.
• W2087663721 cites W2065590100 @default.
• W2087663721 cites W2100926508 @default.
• W2087663721 cites W2101562941 @default.
• W2087663721 cites W2103158733 @default.
• W2087663721 cites W2104380773 @default.
• W2087663721 cites W2126389238 @default.
• W2087663721 cites W2133912342 @default.
• W2087663721 cites W2134667089 @default.
• W2087663721 cites W2135191756 @default.
• W2087663721 cites W2144012207 @default.
• W2087663721 cites W2149296540 @default.
• W2087663721 cites W2149940840 @default.
• W2087663721 cites W2163909934 @default.
• W2087663721 cites W2166785990 @default.
• W2087663721 cites W2171391775 @default.
• W2087663721 doi "https://doi.org/10.1016/j.diagmicrobio.2013.10.020" @default.
• W2087663721 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24582578" @default.
• W2087663721 hasPublicationYear "2014" @default.
• W2087663721 type Work @default.
• W2087663721 sameAs 2087663721 @default.
• W2087663721 citedByCount "15" @default.
• W2087663721 countsByYear W20876637212014 @default.
• W2087663721 countsByYear W20876637212015 @default.
• W2087663721 countsByYear W20876637212016 @default.
• W2087663721 countsByYear W20876637212017 @default.
• W2087663721 countsByYear W20876637212019 @default.
• W2087663721 crossrefType "journal-article" @default.
• W2087663721 hasAuthorship W2087663721A5006715126 @default.
• W2087663721 hasAuthorship W2087663721A5008542312 @default.
• W2087663721 hasAuthorship W2087663721A5026620873 @default.
• W2087663721 hasConcept C104317684 @default.
• W2087663721 hasConcept C126322002 @default.
• W2087663721 hasConcept C174802600 @default.
• W2087663721 hasConcept C2776012195 @default.
• W2087663721 hasConcept C2776520383 @default.
• W2087663721 hasConcept C2776551000 @default.
• W2087663721 hasConcept C2776925733 @default.
• W2087663721 hasConcept C2777058267 @default.
• W2087663721 hasConcept C2779489039 @default.
• W2087663721 hasConcept C2779708577 @default.
• W2087663721 hasConcept C2781253189 @default.
• W2087663721 hasConcept C501593827 @default.
• W2087663721 hasConcept C523546767 @default.
• W2087663721 hasConcept C534529494 @default.
• W2087663721 hasConcept C54355233 @default.
• W2087663721 hasConcept C547475151 @default.
• W2087663721 hasConcept C55493867 @default.
• W2087663721 hasConcept C71924100 @default.
• W2087663721 hasConcept C86803240 @default.
• W2087663721 hasConcept C89423630 @default.
• W2087663721 hasConceptScore W2087663721C104317684 @default.
• W2087663721 hasConceptScore W2087663721C126322002 @default.
• W2087663721 hasConceptScore W2087663721C174802600 @default.
• W2087663721 hasConceptScore W2087663721C2776012195 @default.
• W2087663721 hasConceptScore W2087663721C2776520383 @default.
• W2087663721 hasConceptScore W2087663721C2776551000 @default.
• W2087663721 hasConceptScore W2087663721C2776925733 @default.
• W2087663721 hasConceptScore W2087663721C2777058267 @default.
• W2087663721 hasConceptScore W2087663721C2779489039 @default.
• W2087663721 hasConceptScore W2087663721C2779708577 @default.
• W2087663721 hasConceptScore W2087663721C2781253189 @default.
• W2087663721 hasConceptScore W2087663721C501593827 @default.
• W2087663721 hasConceptScore W2087663721C523546767 @default.
• W2087663721 hasConceptScore W2087663721C534529494 @default.
• W2087663721 hasConceptScore W2087663721C54355233 @default.
• W2087663721 hasConceptScore W2087663721C547475151 @default.
• W2087663721 hasConceptScore W2087663721C55493867 @default.
• W2087663721 hasConceptScore W2087663721C71924100 @default.
• W2087663721 hasConceptScore W2087663721C86803240 @default.
• W2087663721 hasConceptScore W2087663721C89423630 @default.
• W2087663721 hasIssue "4" @default.
• W2087663721 hasLocation W20876637211 @default.
• W2087663721 hasLocation W20876637212 @default.
• W2087663721 hasOpenAccess W2087663721 @default.
• W2087663721 hasPrimaryLocation W20876637211 @default.
• W2087663721 hasRelatedWork W1975352433 @default.
• W2087663721 hasRelatedWork W1983198373 @default.
• W2087663721 hasRelatedWork W2017752285 @default.
• W2087663721 hasRelatedWork W2058341983 @default.
• W2087663721 hasRelatedWork W2082877365 @default.
• W2087663721 hasRelatedWork W2125452755 @default.
• W2087663721 hasRelatedWork W2467754550 @default.
• W2087663721 hasRelatedWork W2515647780 @default.
• W2087663721 hasRelatedWork W3037580570 @default.

• next